Integrative Practitioner’s Top Articles of 2023

Addressing the Ozempic Craze in Clinical Practice

Semaglutide, tradename Ozempic, is an injectable drug that people with type 2 diabetes take weekly to control their blood sugar levels. It also causes weight loss, a key advantage for some people with diabetes. 

“Uncontrolled type 2 diabetes and the relentless damage that unhealthy blood sugar levels can have on the body results in serious consequences,” explained diabetes expert Beverly Yates, ND, the creator of the Yates Protocol to help people thrive with diabetes and the author of the book Heart Health for Black Women. “For these individuals with uncontrolled type 2 diabetes, pharmaceutical interventions such as semaglutide can be a game changer.”

There is no question that semaglutide does in fact lead to weight loss. In a 2022 study that followed more than 300 overweight or obese adults with at least one weight-related comorbidity for two years, semaglutude resulted in 15.3 percent weight loss compared to 2.6 percent in the placebo group. Another 2022 study resulted in a nearly six percent weight loss at three months and nearly 11 percent at six months.

To read more click here.